{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:24:49Z","timestamp":1790925889913,"version":"4.1.0"},"reference-count":244,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal Melbourne Institute of Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Anti-vascular endothelial growth factor (anti-VEGF), laser, and vitrectomy therapy are commonly used for the management of vision-threatening posterior eye disease (PED), but non-invasive alternatives have garnered increasing popularity as proactive preventative strategies for early retinopathy, such as targeted plant-based diets or herbal supplements. However, only some plants contain bioactive compounds that specifically target retinal degeneration and demonstrate potent pharmacological benefits that are cost-effective, safe, and accessible for at-risk individuals. This review pinpoints plant bioactive compounds, specifically polyphenols and carotenoids, that target retinopathy, with a focus on apoptotic, angiogenesis, inflammation, and oxidative pathways leading to visible, functional, and vascular macula improvements. Innovations accelerating therapeutic applications of these botanicals for ocular delivery were then explored. Finally, advancements in disease assessments and the computational methods for early retinopathy biomarker diagnosis and treatment, particularly designed to bio-prospect plant-based therapies, were also reviewed to guide future developments and address translational limitations.<\/jats:p>","DOI":"10.1007\/s43440-025-00778-7","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:53:53Z","timestamp":1756342433000},"page":"123-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-invasive pharmacological advances in early retinopathy treatment: bioactive herbal compounds, polymer delivery systems, and computational bioprospecting of functional targets"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4315-3184","authenticated-orcid":false,"given":"Christopher Busayo","family":"Olowosoke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-7187","authenticated-orcid":false,"given":"Thilini","family":"Thrimawithana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-6040","authenticated-orcid":false,"given":"Tien","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"778_CR1","doi-asserted-by":"publisher","first-page":"1077669","DOI":"10.3389\/fendo.2022.1077669","volume":"13","author":"T-E Tan","year":"2023","unstructured":"Tan T-E, Wong TY. Diabetic retinopathy: looking forward to 2030. Front Endocrinol (Lausanne). 2023;13:1077669.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"778_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/nu11040771","volume":"11","author":"MG Rossino","year":"2019","unstructured":"Rossino MG, Casini G. Nutraceuticals for the treatment of diabetic retinopathy. Nutrients. 2019;11(4):771.","journal-title":"Nutrients"},{"issue":"9","key":"778_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/pharmaceutics14091852","volume":"14","author":"AH Algan","year":"2022","unstructured":"Algan AH, Gungor-Ak A, Karatas A. Nanoscale delivery systems of lutein: an updated review from a pharmaceutical perspective. Pharmaceutics. 2022;14(9):1852.","journal-title":"Pharmaceutics"},{"issue":"139","key":"778_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.30699\/jambs.30.139.138","volume":"30","author":"N Ziamajidi","year":"2022","unstructured":"Ziamajidi N, Abbasalipourkabir R, Lotfi F, Goodarzi MT. Aqueous Garlic extract alleviates oxidative stress and inflammation in retinal tissue of rats with diabetes type 2. J Adv Med Biomed Res. 2022;30(139):138\u201345.","journal-title":"J Adv Med Biomed Res"},{"issue":"3","key":"778_CR5","first-page":"457","volume":"11","author":"R Amin","year":"2022","unstructured":"Amin R, Shariff MA, Purwanita P, Saleh MI. Efficacy of Sambiloto extracts, andrographis paniculate, (Burm. F) in inhibiting diabetic retinopathy progression: an in vivo study. Rep Biochem Mol Biol. 2022;11(3):457\u201364.","journal-title":"Rep Biochem Mol Biol"},{"key":"778_CR6","doi-asserted-by":"publisher","first-page":"112773","DOI":"10.1016\/j.jep.2020.112773","volume":"255","author":"Z Huating","year":"2020","unstructured":"Huating Z, Yingying G, Jingyun Z, Kai W, Tong J, Haiying W, et al. The effect of total lignans from fructus arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats. J Ethnopharmacol. 2020;255:112773.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"778_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/nu8090585","volume":"8","author":"J Kim","year":"2016","unstructured":"Kim J, Jo K, Lee I-S, Kim C-S, Kim J. The extract of aster koraiensis prevents retinal pericyte apoptosis in diabetic rats and its active compound, chlorogenic acid inhibits AGE formation and AGE\/RAGE interaction. Nutrients. 2016;8(9):585.","journal-title":"Nutrients"},{"key":"778_CR8","doi-asserted-by":"publisher","first-page":"728256","DOI":"10.3389\/fphar.2022.728256","volume":"13","author":"L Kong","year":"2022","unstructured":"Kong L, Sun Y, Sun H, Zhang A-H, Zhang B, Ge N, et al. Chinmedomics strategy for elucidating the Pharmacological effects and discovering bioactive compounds from Keluoxin against diabetic retinopathy. Front Pharmacol. 2022;13:728256.","journal-title":"Front Pharmacol"},{"key":"778_CR9","doi-asserted-by":"publisher","first-page":"133816","DOI":"10.1016\/j.ijbiomac.2024.133816","volume":"277","author":"A Saheem","year":"2024","unstructured":"Saheem A, Mohammad FAA, Sultan A, Saif K, Mahvish K, Mohd WAK, et al. Aldose reductase inhibitory and antiglycation properties of phytoconstituents of cichorium intybus: potential therapeutic role in diabetic retinopathy. Int J Biol Macromol. 2024;277:133816.","journal-title":"Int J Biol Macromol"},{"issue":"s2","key":"778_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1463-5224.2012.01018.x","volume":"15","author":"CK Hu","year":"2012","unstructured":"Hu CK, Lee YJ, Colitz CM, Chang CJ, Lin CT. The protective effects of Lycium barbarum and Chrysanthemum morifolum on diabetic retinopathies in rats. Vet Ophthalmol. 2012;15(s2):65\u201371.","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"778_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.vph.2014.04.007","volume":"62","author":"C-Y Gong","year":"2014","unstructured":"Gong C-Y, Yu Z-Y, Lu B, Yang L, Sheng Y-C. Ethanol extract of dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vascul Pharmacol. 2014;62(3):134\u201342.","journal-title":"Vascul Pharmacol"},{"key":"778_CR12","doi-asserted-by":"publisher","first-page":"1143923","DOI":"10.3389\/fphar.2023.1143923","volume":"14","author":"EDF De Oliveira","year":"2023","unstructured":"De Oliveira EDF, Brasil A, Herculano AM, Rosa MA, Gomes BD, Rocha FADF. Neuroprotective effects of A\u00e7a\u00ed (Euterpe Oleracea Mart.) against diabetic retinopathy. Front Pharmacol. 2023;14:1143923.","journal-title":"Front Pharmacol"},{"issue":"6","key":"778_CR13","first-page":"870","volume":"10","author":"X-Y Mei","year":"2017","unstructured":"Mei X-Y, Ling-Yu Z, Zhang T-Y, Lu B. Ji. L-L. Scutellaria Barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. Int J Ophthalmol. 2017;10(6):870.","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"778_CR14","first-page":"1275","volume":"20","author":"D Nasiry","year":"2017","unstructured":"Nasiry D, Khalatbary AR, Ahmadvand H. Therapeutic potential of juglans regia L. leaf extract against diabetic retinopathy in rat. Iran J Basic Med Sci. 2017;20(11):1275.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"778_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/15569527.2016.1144610","volume":"36","author":"EK Kilari","year":"2017","unstructured":"Kilari EK, Putta S. Delayed progression of diabetic cataractogenesis and retinopathy by Litchi chinensis in STZ-induced diabetic rats. Cutan Ocul Toxicol. 2017;36(1):52\u20139.","journal-title":"Cutan Ocul Toxicol"},{"key":"778_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jep.2016.05.039","volume":"189","author":"Z Lingyu","year":"2016","unstructured":"Lingyu Z, Tianyu Z, Bin L, Zengyang Y, Xiyu M, Palida A, et al. Lonicerae japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. J Ethnopharmacol. 2016;189:117\u201325.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"778_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bcp.2011.07.089","volume":"82","author":"MK Song","year":"2011","unstructured":"Song MK, Noeris KS, Basil DR, Tom H-WH. Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-\u03b3-dependent gene transcription in human retinal pigment epithelial cells: possible implications for diabetic retinopathy treatmen. Biochem Pharmacol. 2011;82(9):1209\u201318.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"778_CR18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00394-016-1214-0","volume":"56","author":"AM Mahmoud","year":"2017","unstructured":"Mahmoud AM, Abd El-Twab SM, Abdel-Reheim ES. Consumption of polyphenol-rich Morus Alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism. Eur J Nutr. 2017;56(4):1671\u201384.","journal-title":"Eur J Nutr"},{"issue":"1","key":"778_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/5290161","volume":"2017","author":"J Wattanathorn","year":"2017","unstructured":"Wattanathorn J, Thiraphatthanavong P, Thukham-Mee W, Muchimapura S, Wannanond P, Tong-Un T. Anticataractogenesis and antiretinopathy effects of the novel protective agent containing the combined extract of Mango and Vietnamese coriander in STZ-Diabetic rats. Oxid Med Cell Longev. 2017;2017(1):1\u201313.","journal-title":"Oxid Med Cell Longev"},{"key":"778_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.01.052","volume":"562","author":"SK Young","year":"2007","unstructured":"Young SK, Dong HJ, Nan HK, Yun ML, Jin SK. Effect of Magnolol on TGF-\u03b21 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions. Eur J Pharmacol. 2007;562:1\u20132.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"778_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4103\/2221-1691.248093","volume":"8","author":"A Abdulqader","year":"2018","unstructured":"Abdulqader A, Ali F, Ismail A, Esa NM. Gac fruit extracts ameliorate proliferation and modulate angiogenic markers of human retinal pigment epithelial cells under high glucose conditions. Asian Pac J Trop Biomed. 2018;8(12):571\u20139.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"4","key":"778_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/jop.2012.0089","volume":"29","author":"GS Kumar","year":"2013","unstructured":"Kumar GS, Binit K, Srinivasan BP, Tapas CN, Sushma S, Rohit S, et al. Retinoprotective effects of Moringa Oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J Ocul Pharmacol Ther. 2013;29(4):419\u201326.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"778_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF02912939","volume":"21","author":"EM Halim","year":"2006","unstructured":"Halim EM, Mukhopadhyay AK. Effect of ocimum sanctum (Tulsi) and vitamin E on biochemical parameters and retinopathy in streptozotocin induced diabetic rats. Indian J Clin Biochem. 2006;21(2):181\u20138.","journal-title":"Indian J Clin Biochem"},{"issue":"2","key":"778_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ptr.4719","volume":"27","author":"S Sen","year":"2013","unstructured":"Sen S, Chen S, Wu Y, Feng B, Lui EK, Chakrabarti S. Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. Phytother Res. 2013;27(2):290\u20138.","journal-title":"Phytother Res"},{"issue":"3","key":"778_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/nu8030140","volume":"8","author":"E Sohn","year":"2016","unstructured":"Sohn E, Kim J, Kim C-S, Lee Y, Kim J. Extract of polygonum cuspidatum attenuates diabetic retinopathy by inhibiting the High-Mobility group Box-1 (HMGB1) signaling pathway in Streptozotocin-Induced diabetic rats. Nutrients. 2016;8(3):140.","journal-title":"Nutrients"},{"issue":"5","key":"778_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3390\/antiox10050717","volume":"10","author":"R Bautista-P\u00e9rez","year":"2021","unstructured":"Bautista-P\u00e9rez R, Cano-Mart\u00ednez A, Guti\u00e9rrez-Vel\u00e1zquez E, Mart\u00ednez-Rosas M, P\u00e9rez-Guti\u00e9rrez RM, Jim\u00e9nez-G\u00f3mez F, et al. Spinach methanolic extract attenuates the retinal degeneration in diabetic rats. Antioxidants. 2021;10(5):717.","journal-title":"Antioxidants"},{"key":"778_CR27","doi-asserted-by":"crossref","unstructured":"Shyam SA, Salma N, Suresh KG, Sushma S. Prevention and management of diabetic retinopathy in STZ diabetic rats by Tinospora cordifolia and its molecular mechanisms. Food Chem Toxicol. 2012;50(9).","DOI":"10.1016\/j.fct.2012.05.057"},{"issue":"1\u20132","key":"778_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-013-1893-2","volume":"388","author":"SK Gupta","year":"2014","unstructured":"Gupta SK, Kumar B, Nag TC, Srinivasan BP, Srivastava S, Gaur S, et al. Effects of Trigonella foenum-graecum (L.) on retinal oxidative stress, and Proinflammatory and angiogenic molecular biomarkers in streptozotocin-induced diabetic rats. Mol Cell Biochem. 2014;388(1\u20132):1\u20139.","journal-title":"Mol Cell Biochem"},{"key":"778_CR29","doi-asserted-by":"crossref","unstructured":"Kim I, Seo J, Lee DH, Kim Y-H, Kim J-H, Wie M-B et al. Ulmus Davidiana 60% edible ethanolic extract for prevention of pericyte apoptosis in diabetic retinopathy. Front Endocrinol (Lausanne). 2023;14.","DOI":"10.3389\/fendo.2023.1138676"},{"key":"778_CR30","doi-asserted-by":"crossref","unstructured":"Ma H, Li J. The ginger extract could improve diabetic retinopathy by inhibiting the expression of e\/inos and G6PDH, apoptosis, inflammation, and angiogenesis. J Food Biochem. 2022;46(5).","DOI":"10.1111\/jfbc.14084"},{"key":"778_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.vph.2015.08.015","volume":"76","author":"T-Y Hong","year":"2016","unstructured":"Hong T-Y, Thing-Fong T, Shorong-Shii L, I-Min L. The ethanol extract of Zingiber Zerumbet rhizomes mitigates vascular lesions in the diabetic retina. Vascul Pharmacol. 2016;76:18\u201327.","journal-title":"Vascul Pharmacol"},{"key":"778_CR32","first-page":"3","volume-title":"Introduction to the different classes of natural products","author":"K Springob","year":"2009","unstructured":"Springob K, Kutchan TM. Introduction to the different classes of natural products. Plant-derived Natural Products: Springer US; 2009. pp. 3\u201350."},{"issue":"10","key":"778_CR33","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/nu12103169","volume":"12","author":"AL Matos","year":"2020","unstructured":"Matos AL, Bruno DF, Ambr\u00f3sio AF, Santos PF. The benefits of flavonoids in diabetic retinopathy. Nutrients. 2020;12(10):3169.","journal-title":"Nutrients"},{"issue":"8","key":"778_CR34","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1211\/jpp.62.08.0001","volume":"62","author":"S Majumdar","year":"2010","unstructured":"Majumdar S, Srirangam R. Potential of the bioflavonoids in the prevention\/treatment of ocular disorders. J Pharm Pharmacol. 2010;62(8):951\u201365.","journal-title":"J Pharm Pharmacol"},{"key":"778_CR35","doi-asserted-by":"crossref","unstructured":"Cveji\u0107 J, Krstono\u0161i\u0107 MA, Mikuli\u0107 M. Milji\u0107 U. Polyphenols; 2022.","DOI":"10.1016\/B978-0-323-85052-0.00012-X"},{"issue":"3","key":"778_CR36","doi-asserted-by":"publisher","first-page":"e0194603","DOI":"10.1371\/journal.pone.0194603","volume":"13","author":"T Tsai","year":"2018","unstructured":"Tsai T, Kuehn S, Tsiampalis N, Vu M-K, Kakkassery V, Stute G, et al. Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients. PLoS ONE. 2018;13(3):e0194603.","journal-title":"PLoS ONE"},{"issue":"5","key":"778_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/10408363.2015.1129530","volume":"53","author":"SF Nabavi","year":"2016","unstructured":"Nabavi SF, Barber AJ, Spagnuolo C, Russo GL, Daglia M, Nabavi SM, et al. Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy. Crit Rev Clin Lab Sci. 2016;53(5):293\u2013312.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"778_CR38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/antiox12061237","volume":"12","author":"GB Fanaro","year":"2023","unstructured":"Fanaro GB, Marques MR, Calaza KC, Brito R, Pessoni AM, Mendon\u00e7a HR, et al. New insights on dietary polyphenols for the management of oxidative stress and neuroinflammation in diabetic retinopathy. Antioxidants. 2023;12(6):1237.","journal-title":"Antioxidants"},{"issue":"6","key":"778_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.33263\/BRIAC136.588","volume":"13","author":"TB Emran","year":"2023","unstructured":"Emran TB, Akiful HM, Purnachandra RG, Laliteshwar P. A renewed concept on diabetic retinopathy: polyphenols as a choice of solution. Biointerface Res Appl Chem. 2023;13(6):588.","journal-title":"Biointerface Res Appl Chem"},{"issue":"1","key":"778_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0891-5849(00)00329-4","volume":"29","author":"KA Youdim","year":"2000","unstructured":"Youdim KA, Martin A, Joseph JA. Incorporation of the Elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Radic Biol Med. 2000;29(1):51\u201360.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"778_CR41","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.3390\/molecules190812827","volume":"19","author":"W-Y Huang","year":"2014","unstructured":"Huang W-Y, Liu Y-M, Wang J, Wang X-N, Li C-Y. Anti-Inflammatory effect of the blueberry anthocyanins Malvidin-3-Glucoside and Malvidin-3-Galactoside in endothelial cells. Molecules. 2014;19(8):12827\u201341.","journal-title":"Molecules"},{"issue":"9","key":"778_CR42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bjophthalmol-2011-300110","volume":"95","author":"V Jhanji","year":"2011","unstructured":"Jhanji V, Huanming L, Kasin L, Vincent Y-WL, Shao-Fen H, Chi-Pui P, et al. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models. Br J Ophthalmol. 2011;95(9):1309\u201315.","journal-title":"Br J Ophthalmol"},{"key":"778_CR43","doi-asserted-by":"publisher","first-page":"108065","DOI":"10.1016\/j.exer.2020.108065","volume":"196","author":"J Du","year":"2020","unstructured":"Du J, Wang Y, Tu Y, Guo Y, Sun X, Xu X, et al. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS\/TXNIP\/NLRP3 inflammasome axis in retinal M\u00fcller cells. Exp Eye Res. 2020;196:108065.","journal-title":"Exp Eye Res"},{"issue":"12","key":"778_CR44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/nu8120782","volume":"8","author":"M-K Kang","year":"2016","unstructured":"Kang M-K, Park S-H, Kim Y-H, Lee E-J, Antika L, Kim D, et al. Dietary compound Chrysin inhibits retinal neovascularization with abnormal capillaries in db\/db mice. Nutrients. 2016;8(12):782.","journal-title":"Nutrients"},{"key":"778_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biopha.2018.02.054","volume":"101","author":"X Chen","year":"2018","unstructured":"Chen X, Han R, Hao P, Wang L, Liu M, Jin M, et al. Nepetin inhibits IL-1\u03b2 induced inflammation via NF-\u03baB and MAPKs signaling pathways in ARPE-19 cells. Biomed Pharmacother. 2018;101:87\u201393.","journal-title":"Biomed Pharmacother"},{"key":"778_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/DMSO.S290633","volume":"14","author":"W Li","year":"2021","unstructured":"Li W, Xiao H. Dihydromyricetin alleviates high Glucose-Induced oxidative stress and apoptosis in human retinal pigment epithelial cells by downregulating miR-34a expression. Diabetes Metabolic Syndrome Obes. 2021;14:387\u201397.","journal-title":"Diabetes Metabolic Syndrome Obes"},{"key":"778_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.11.006","volume":"65","author":"T Zhang","year":"2019","unstructured":"Zhang T, Mei X, Ouyang H, Lu B, Yu Z, Wang Z, et al. Natural flavonoid Galangin alleviates microglia-trigged blood\u2013retinal barrier dysfunction during the development of diabetic retinopathy. J Nutr Biochem. 2019;65:1\u201314.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"778_CR48","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/ijms13010866","volume":"13","author":"H Xin","year":"2012","unstructured":"Xin H, Zhou F, Liu T, Li G-Y, Liu J, Gao Z-Z, et al. Icariin ameliorates Streptozotocin-Induced diabetic retinopathy in vitro and in vivo. Int J Mol Sci. 2012;13(1):866\u201378.","journal-title":"Int J Mol Sci"},{"key":"778_CR49","doi-asserted-by":"crossref","unstructured":"Xu XH, Zhao C, Peng Q, Xie P, Liu QH. Kaempferol inhibited VEGF and PGF expression and in vitro angiogenesis of HRECs under diabetic-like environment. Braz J Med Biol Res. 2017;50(3).","DOI":"10.1590\/1414-431x20165396"},{"issue":"1","key":"778_CR50","doi-asserted-by":"publisher","first-page":"25509","DOI":"10.1038\/srep25509","volume":"6","author":"RS Sulaiman","year":"2016","unstructured":"Sulaiman RS, Merrigan S, Quigley J, Qi X, Lee B, Boulton ME, et al. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Sci Rep. 2016;6(1):25509.","journal-title":"Sci Rep"},{"key":"778_CR51","first-page":"556","volume":"14","author":"JH Kim","year":"2008","unstructured":"Kim JH, Kim JH, Yu YS, Jun H-O, Kwon HJ, Park KH, et al. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor. Mol Vis. 2008;14:556.","journal-title":"Mol Vis"},{"issue":"6a","key":"778_CR52","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1111\/j.1582-4934.2008.00243.x","volume":"12","author":"JH Kim","year":"2008","unstructured":"Kim JH, Kim JH, Yu YS, Shin JY, Lee HY, Kim KW. Deguelin inhibits retinal neovascularization by down-regulation of HIF\u20101\u03b1 in oxygen\u2010induced retinopathy. J Cell Mol Med. 2008;12(6a):2407\u201315.","journal-title":"J Cell Mol Med"},{"key":"778_CR53","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.2147\/DDDT.S114022","volume":"10","author":"J Wu","year":"2016","unstructured":"Wu J, Ke X, Ma N, Wang W, Fu W, Zhang H, et al. Formononetin, an active compound of Astragalus Membranaceus (Fisch) bunge, inhibits hypoxia-induced retinal neovascularization via the HIF-1\u03b1\/VEGF signaling pathway. Drug Des Devel Ther. 2016;10:3071\u201381.","journal-title":"Drug Des Devel Ther"},{"key":"778_CR54","first-page":"2033","volume":"16","author":"AS Ibrahim","year":"2010","unstructured":"Ibrahim AS, Mamdouh ME-S, Alejandro PJ, Gregory IL. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis. 2010;16:2033.","journal-title":"Mol Vis"},{"issue":"5","key":"778_CR55","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1167\/iovs.05-0580","volume":"47","author":"C Premanand","year":"2006","unstructured":"Premanand C, Rema M, Sameer MZ, Sujatha M, Balasubramanyam M. Effect of Curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Investig Ophthalmol Vis Sci. 2006;47(5):2179.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"778_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7584691","volume":"2017","author":"J Li","year":"2017","unstructured":"Li J, Yu S, Ying J, Shi T, Wang P, Resveratrol Prevents. ROS-Induced apoptosis in high Glucose\u2010Treated retinal capillary endothelial cells via the activation of AMPK\/Sirt1\/PGC\u20101\u03b1 pathway. Oxid Med Cell Longev. 2017;2017(1):1\u201310.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"778_CR57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/labinvest.2011.132","volume":"92","author":"S Miyake","year":"2012","unstructured":"Miyake S, Takahashi N, Sasaki M, Kobayashi S, Tsubota K, Ozawa Y. Vision preservation during retinal inflammation by anthocyanin-rich Bilberry extract: cellular and molecular mechanism. Lab Invest. 2012;92(1):102\u20139.","journal-title":"Lab Invest"},{"key":"778_CR58","doi-asserted-by":"crossref","unstructured":"Ren JL, Yu QX, Liang WC, Leung PY, Ng TK, Chu WK et al. Green tea extract attenuates LPS-induced retinal inflammation in rats. Sci Rep. 2018;8(1).","DOI":"10.1038\/s41598-017-18888-5"},{"issue":"1","key":"778_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bcp.2012.03.019","volume":"84","author":"C Bucolo","year":"2012","unstructured":"Bucolo C, Gian M, Leggio F, Drago, Salomone S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol. 2012;84(1):88\u201392.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"778_CR60","doi-asserted-by":"publisher","first-page":"12868","DOI":"10.3390\/molecules171112868","volume":"17","author":"X Shi","year":"2012","unstructured":"Shi X, Liao S, Mi H, Guo C, Qi D, Li F, et al. Hesperidin prevents retinal and plasma abnormalities in Streptozotocin-Induced diabetic rats. Molecules. 2012;17(11):12868\u201381.","journal-title":"Molecules"},{"issue":"3","key":"778_CR61","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/biomedicines12030552","volume":"12","author":"R Alshaman","year":"2024","unstructured":"Alshaman R, Kolieb E, El-Sayed RM, Gouda SG, Alattar A, Zaitone SA, et al. Computational and experimental approaches exploring the role of Hesperetin in improving autophagy in rat diabetic retinopathy. Biomedicines. 2024;12(3):552.","journal-title":"Biomedicines"},{"issue":"10","key":"778_CR62","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/nu9101161","volume":"9","author":"D Al-Dosari","year":"2017","unstructured":"Al-Dosari D, Ahmed M, Al-Rejaie S, Alhomida A, Ola M. Flavonoid naringenin attenuates oxidative stress, apoptosis and improves neurotrophic effects in the diabetic rat retina. Nutrients. 2017;9(10):1161.","journal-title":"Nutrients"},{"issue":"5","key":"778_CR63","first-page":"594","volume":"45","author":"W Wang","year":"2018","unstructured":"Wang W, Yuan Z, Wei J, Yiqiao X, Anhuai Y. Catechin weakens diabetic retinopathy by inhibiting the expression of NF-\u03baB signaling pathway-mediated inflammatory factors. Ann Clin Lab Sci. 2018;45(5):594\u2013600.","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"778_CR64","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1167\/iovs.08-2642","volume":"50","author":"L-P Yang","year":"2009","unstructured":"Yang L-P, Sun H-L, Wu L-M, Guo X-J, Dou H-L, Tso MOM, et al. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Investig Ophthalmol Vis Sci. 2009;50(5):2319.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"778_CR65","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1556\/2060.2021.00148","volume":"108","author":"Y Yang","year":"2021","unstructured":"Yang Y, Zhou M, Liu H. Luteolin, an Aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP\/NOX4 signalling pathway: experimental and molecular Docking study. Physiol Int. 2021;108(2):172\u201384.","journal-title":"Physiol Int"},{"issue":"6","key":"778_CR66","first-page":"870","volume":"10","author":"XY Mei","year":"2017","unstructured":"Mei XY, Zhou LY, Zhang TY, Lu B, Ji LL. Scutellaria Barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. Int J Ophthalmol. 2017;10(6):870\u20137.","journal-title":"Int J Ophthalmol"},{"key":"778_CR67","doi-asserted-by":"crossref","unstructured":"Karimi R, Bakhshi A, Dayati P, Abazari O, Shahidi M, Savaee M et al. Silymarin reduces retinal microvascular damage in streptozotocin-induced diabetic rats. Sci Rep. 2022;12(1).","DOI":"10.1038\/s41598-022-20297-2"},{"key":"778_CR68","doi-asserted-by":"crossref","unstructured":"Chai G-R, Liu S, Yang H-W, Chen X-L. Quercetin protects against diabetic retinopathy in rats by inducing Heme oxygenase-1 expression. Neural Regeneration Res. 2021;16(7).","DOI":"10.4103\/1673-5374.301027"},{"issue":"2","key":"778_CR69","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12031-015-0561-2","volume":"56","author":"MS Ola","year":"2015","unstructured":"Ola MS, Ahmed MM, Ahmad R, Abuohashish HM, Al-Rejaie SS, Alhomida AS. Neuroprotective effects of Rutin in Streptozotocin-Induced diabetic rat retina. J Mol Neurosci. 2015;56(2):440\u20138.","journal-title":"J Mol Neurosci"},{"issue":"6","key":"778_CR70","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jcjd.2018.03.008","volume":"42","author":"ME Mehrabadi","year":"2018","unstructured":"Mehrabadi ME, Zahra S, Saeid B, Mitra P. Effect of Biochanin A on retina levels of vascular endothelial growth factor, tumor necrosis Factor-Alpha and Interleukin-1Beta in rats with Streptozotocin-Induced diabetes. Can J Diabetes. 2018;42(6):639\u201344.","journal-title":"Can J Diabetes"},{"key":"778_CR71","doi-asserted-by":"publisher","first-page":"118779","DOI":"10.1016\/j.lfs.2020.118779","volume":"265","author":"AP Laddha","year":"2021","unstructured":"Laddha AP, Kulkarni YA. Daidzein ameliorates diabetic retinopathy in experimental animals. Life Sci. 2021;265:118779.","journal-title":"Life Sci"},{"issue":"5","key":"778_CR72","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s11033-008-9288-2","volume":"36","author":"Y Teng","year":"2009","unstructured":"Teng Y, Cui H, Yang M, Song H, Zhang Q, Su Y, et al. Protective effect of puerarin on diabetic retinopathy in rats. Mol Biol Rep. 2009;36(5):1129\u201333.","journal-title":"Mol Biol Rep"},{"key":"778_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000486574","volume":"20180329","author":"F Yang","year":"2018","unstructured":"Yang F, Jinqiang Y, Ke F, Lan M, Li D, Tan K, et al. Curcumin alleviates diabetic retinopathy in experimental diabetic rats. Ophthalmic Res. 2018;20180329:43\u201354.","journal-title":"Ophthalmic Res"},{"issue":"6","key":"778_CR74","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S1734-1140(12)70948-9","volume":"64","author":"FG Soufi","year":"2012","unstructured":"Soufi FG, Mohammad-Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress \u2013 nuclear factor \u03baB \u2013 apoptosis pathway. Pharmacol Rep. 2012;64(6):1505\u201314.","journal-title":"Pharmacol Rep"},{"issue":"5","key":"778_CR75","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/bjophthalmol-2016-309814","volume":"101","author":"K Neelam","year":"2017","unstructured":"Neelam K, Catherina JG, Katherine L, Chee CY, Kah-Guan AE. Putative protective role of lutein and Zeaxanthin in diabetic retinopathy. Br J Ophthalmol. 2017;101(5):551\u20138.","journal-title":"Br J Ophthalmol"},{"key":"778_CR76","doi-asserted-by":"crossref","unstructured":"Nguyen D, Thrimawithana T, Piva TJ, Grando D, Huynh T. Benefits of plant carotenoids against age-related macular degeneration. J Funct Foods. 2023;106.","DOI":"10.1016\/j.jff.2023.105597"},{"issue":"4","key":"778_CR77","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.preteyeres.2012.03.002","volume":"31","author":"A Kijlstra","year":"2012","unstructured":"Kijlstra A, Yuan T, Elton RK, Tos TB. Lutein: more than just a filter for blue light. Prog Retin Eye Res. 2012;31(4):303\u201315.","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"778_CR78","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jnutbio.2011.01.006","volume":"23","author":"M Sasaki","year":"2012","unstructured":"Sasaki M, Kenya Yuki T, Kurihara S, Miyake K, Noda S, Kobayashi, et al. Biological role of lutein in the light-induced retinal degeneration. J Nutr Biochem. 2012;23(5):423\u20139.","journal-title":"J Nutr Biochem"},{"key":"778_CR79","doi-asserted-by":"crossref","unstructured":"Lem D, Gierhart D, Davey P. Can nutrition play a role in ameliorating digital. Eye Strain? Nutrients. 2022;14(19).","DOI":"10.3390\/nu14194005"},{"issue":"4","key":"778_CR80","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/nu5041169","volume":"5","author":"E-S Abdel-Aal","year":"2013","unstructured":"Abdel-Aal E-S, Akhtar H, Zaheer K, Ali R. Dietary sources of lutein and Zeaxanthin carotenoids and their role in eye health. Nutrients. 2013;5(4):1169\u201385.","journal-title":"Nutrients"},{"issue":"3","key":"778_CR81","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/ijfs.16938","volume":"59","author":"NK Fitzpatrick","year":"2024","unstructured":"Fitzpatrick NK, Chachay V, Shore A, Jackman S, Capra S, Bowtell J, et al. Building food composition tables: extraction methods to measure lutein and Zeaxanthin concentrations in select Australian foods. Int J Food Sci Technol. 2024;59(3):1864\u201375.","journal-title":"Int J Food Sci Technol"},{"issue":"2","key":"778_CR82","first-page":"152","volume":"22","author":"R Hajare","year":"2013","unstructured":"Hajare R, Ananya R, Tharachand CS, Avadhani MN, Selvaraj IC. Extraction and quantification of antioxidant lutein from various plant sources. Int J Pharm Sci Rev Res. 2013;22(2):152\u20137.","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"11","key":"778_CR83","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0278-6915(02)00131-X","volume":"40","author":"CL Kruger","year":"2002","unstructured":"Kruger CL, Murphy M, DeFreitas Z, Pfannkuch F, Heimbach J. An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product. Food Chem Toxicol. 2002;40(11):1535\u201349.","journal-title":"Food Chem Toxicol"},{"issue":"sup6","key":"778_CR84","doi-asserted-by":"publisher","first-page":"S567","DOI":"10.1080\/07315724.2004.10719427","volume":"23","author":"JD Ribaya-Mercado","year":"2004","unstructured":"Ribaya-Mercado JD, Blumberg JB. Lutein and Zeaxanthin and their potential roles in disease prevention. J Am Coll Nutr. 2004;23(sup6):S567\u201387.","journal-title":"J Am Coll Nutr"},{"key":"778_CR85","doi-asserted-by":"crossref","unstructured":"Sanlier N, Yildiz E, Ozler E. An overview on the effects of some carotenoids on health: lutein and Zeaxanthin. Curr Nutr Rep. 2024.","DOI":"10.1007\/s13668-024-00579-z"},{"key":"778_CR86","doi-asserted-by":"publisher","first-page":"105994","DOI":"10.1016\/j.ultsonch.2022.105994","volume":"85","author":"R Shaziya Manzoor, Rubiya","year":"2022","unstructured":"Shaziya Manzoor, Rubiya R, Bibhu PP, Vasudha S, Mohd A. Green extraction of lutein from marigold flower petals, process optimization and its potential to improve the oxidative stability of sunflower oil. Ultrason Sonochem. 2022;85:105994.","journal-title":"Ultrason Sonochem"},{"issue":"1","key":"778_CR87","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.foodchem.2010.02.034","volume":"122","author":"JM-M Enrique Murillo, Antonio","year":"2010","unstructured":"Enrique Murillo, Antonio JM-M, Falc\u00f3n P. Screening of vegetables and fruits from Panama for rich sources of lutein and Zeaxanthin. Food Chem. 2010;122(1):167\u201372.","journal-title":"Food Chem"},{"issue":"3","key":"778_CR88","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.foodchem.2011.01.115","volume":"127","author":"J Kubola","year":"2011","unstructured":"Kubola J, Sirithon S. Phytochemicals and antioxidant activity of different fruit fractions (peel, pulp, Aril and seed) of Thai Gac (Momordica cochinchinensis Spreng). Food Chem. 2011;127(3):1138\u201345.","journal-title":"Food Chem"},{"issue":"7","key":"778_CR89","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1080\/87559129.2022.2027438","volume":"39","author":"X Zhao","year":"2023","unstructured":"Zhao X, Liang K, Zhu H. Carotenoids in cereals and related foodstuffs: A review of extraction and analysis methods. Food Reviews Int. 2023;39(7):4513\u201328.","journal-title":"Food Reviews Int"},{"key":"778_CR90","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1021\/jf062939v","volume":"55","author":"GK Ellie","year":"2007","unstructured":"Ellie GK, Gebisa E, Bruce RH, Mario GF. Characterization of carotenoid pigments in mature and developing kernels of selected Yellow-Endosperm sorghum varieties. J Agric Food Chem. 2007;55:2619\u201326.","journal-title":"J Agric Food Chem"},{"key":"778_CR91","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.foodchem.2017.07.099","volume":"240","author":"KS Ramesh","year":"2018","unstructured":"Ramesh KS, Young-Soo K. Carotenoid extraction methods: A review of recent developments. Food Chem. 2018;240:90\u2013103.","journal-title":"Food Chem"},{"issue":"2","key":"778_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jfca.2012.04.009","volume":"27","author":"MR Helen","year":"2012","unstructured":"Helen MR, Tawanda M, Emily MRE, Elizabeth JJ. Lutein, zeaxanthin, meso-zeaxanthin content in egg yolk and their absence in fish and seafood. J Food Compost Anal. 2012;27(2):139\u201344.","journal-title":"J Food Compost Anal"},{"issue":"6","key":"778_CR93","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/27697061.2024.2319090","volume":"43","author":"P Kumar","year":"2024","unstructured":"Kumar P, Banik PS, Ohia ES, Moriyama H, Chakraborty S, Wang C-K, et al. Current insights on the photoprotective mechanism of the macular carotenoids, lutein and zeaxanthin: safety, efficacy and Bio-Delivery. J Am Nutr Association. 2024;43(6):505\u201318.","journal-title":"J Am Nutr Association"},{"key":"778_CR94","doi-asserted-by":"crossref","unstructured":"Lima VC, Rosen RB, Farah M. Macular pigment in retinal health and disease. Int J Retina Vitreous. 2016;2(1).","DOI":"10.1186\/s40942-016-0044-9"},{"issue":"12","key":"778_CR95","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1167\/iovs.11-8025","volume":"52","author":"EE Connolly","year":"2011","unstructured":"Connolly EE, Beatty S, Loughman J, Howard AN, Louw MS, Nolan JM. Supplementation with all three macular carotenoids: response, stability, and safety. Investig Ophthalmol Vis Sci. 2011;52(12):9207.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"778_CR96","first-page":"167","volume":"38","author":"PS Bernstein","year":"1997","unstructured":"Bernstein PS, Nikita AB, Edward DT, Robert RR. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci. 1997;38(1):167\u201375.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"778_CR97","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.abb.2012.01.006","volume":"519","author":"P Vachali","year":"2012","unstructured":"Vachali P, Li B, Nelson K, Bernstein PS. Surface plasmon resonance (SPR) studies on the interactions of carotenoids and their binding proteins. Arch Biochem Biophys. 2012;519(1):32\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"778_CR98","doi-asserted-by":"crossref","unstructured":"Crosby-Nwaobi R, Hykin P, Peto T, Sivaprasad S. An exploratory study evaluating the effects of macular carotenoid supplementation in various retinal diseases. Clin Ophthalmol. 2016:835.","DOI":"10.2147\/OPTH.S102798"},{"key":"778_CR99","doi-asserted-by":"crossref","unstructured":"EFSA PoDP, Nutrition and Allergies (NDA). Guidance on the scientific requirements for health claims related to functions of the nervous system, including psychological functions. EFSA J. 2012;10(7).","DOI":"10.2903\/j.efsa.2012.2816"},{"issue":"12","key":"778_CR100","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1167\/iovs.12-10690","volume":"53","author":"J Loughman","year":"2012","unstructured":"Loughman J, Nolan MJ, Howard NA, Connolly E, Meagher K, Beatty S. The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci. 2012;53(12):7871\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"778_CR101","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1167\/iovs.16-21087","volume":"58","author":"MJ Stringham","year":"2017","unstructured":"Stringham MJ, O\u2019Brien JK, Stringham TN. Contrast sensitivity and lateral Inhibition are enhanced with macular carotenoid supplementation. Investig Ophthalmol Vis Sci. 2017;58(4):2291.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"778_CR102","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1167\/iovs.16-19520","volume":"57","author":"MJ Nolan","year":"2016","unstructured":"Nolan MJ, Power R, Stringham J, Dennison J, Stack J, Kelly D, et al. Enrichment of macular pigment enhances contrast sensitivity in subjects free of retinal disease: central retinal enrichment supplementation Trials \u2013 Report 1. Investig Ophthalmol Vis Sci. 2016;57(7):3429.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"778_CR103","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/bjophthalmol-2014-306534","volume":"100","author":"AP Chous","year":"2016","unstructured":"Chous AP, Richer SP, Gerson JD, Kowluru RA. The diabetes visual function supplement study (DiVFuSS). Br J Ophthalmol. 2016;100(2):227\u201334.","journal-title":"Br J Ophthalmol"},{"key":"778_CR104","doi-asserted-by":"crossref","unstructured":"Moschos MM, Dettoraki M, Tsatsos M, Kitsos G, Kalogeropoulos C. Effect of carotenoids dietary supplementation on macular function in diabetic patients. Eye Vis. 2017;4(1).","DOI":"10.1186\/s40662-017-0088-4"},{"issue":"3","key":"778_CR105","first-page":"303","volume":"4","author":"B-J Hu","year":"2011","unstructured":"Hu B-J, Lin Y-NHS, Ma W-J, Li. X-R. Application of lutein and Zeaxanthin in nonproliferative diabetic retinopathy. Int J Ophthalmol. 2011;4(3):303.","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"778_CR106","first-page":"406","volume":"26","author":"P-C Zhang","year":"2017","unstructured":"Zhang P-C, Chang-Rui W, Zhi-Lun W, Li-Yuan W, Yue H, Shu-Liu S, et al. Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy. Asia Pac J Clin Nutr. 2017;26(3):406\u201311.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"29","key":"778_CR107","doi-asserted-by":"publisher","first-page":"e15404","DOI":"10.1097\/MD.0000000000015404","volume":"98","author":"Y-b Ren","year":"2019","unstructured":"Ren Y-b, Xing-jie Yan-xiuQ, He-qun S, Qi L. Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study. Medicine. 2019;98(29):e15404.","journal-title":"Medicine"},{"key":"778_CR108","doi-asserted-by":"crossref","unstructured":"Wei L, Sun X, Fan C, Li R, Zhou S, Yu H. The pathophysiological mechanisms underlying diabetic retinopathy. Front Cell Dev Biol. 2022;10.","DOI":"10.3389\/fcell.2022.963615"},{"issue":"5","key":"778_CR109","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00125-009-1655-6","volume":"53","author":"M Sasaki","year":"2010","unstructured":"Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, et al. Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia. 2010;53(5):971\u20139.","journal-title":"Diabetologia"},{"issue":"6","key":"778_CR110","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.freeradbiomed.2006.06.023","volume":"41","author":"M Mar\u00eda","year":"2006","unstructured":"Mar\u00eda M, Francisco B-M, George A, Rune B, Jorge B, Emma A, et al. Lutein effect on retina and hippocampus of diabetic mice. Free Radic Biol Med. 2006;41(6):979\u201384.","journal-title":"Free Radic Biol Med"},{"key":"778_CR111","doi-asserted-by":"crossref","unstructured":"Miranda M, Muriach M, Roma J, Bosch-Morell F, Genov\u00e9s JM, Barcia J et al. Oxidative stress in a model of experimental diabetic retinopathy: the utility of peroxinytrite scavengers. Arch Soc Esp Oftalmol. 2006;81(1).","DOI":"10.4321\/S0365-66912006000100007"},{"issue":"11","key":"778_CR112","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3109\/02713680903205238","volume":"34","author":"E Arnal","year":"2009","unstructured":"Arnal E, Miranda M, Johnsen-Soriano S, Alvarez-N\u00f6lting R, D\u00edaz-Llopis M, Araiz J, et al. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res. 2009;34(11):928\u201338.","journal-title":"Curr Eye Res"},{"key":"778_CR113","doi-asserted-by":"crossref","unstructured":"Wang W, Ka CT, Tsz CN, Rajesh KG, Kate LSC, Amy CYL. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2Akita\/+ mice. BMJ Open Diabetes Res Care. 2020;8(1).","DOI":"10.1136\/bmjdrc-2020-001519"},{"issue":"1","key":"778_CR114","doi-asserted-by":"publisher","first-page":"e0146438","DOI":"10.1371\/journal.pone.0146438","volume":"11","author":"P-T Yeh","year":"2016","unstructured":"Yeh P-T, Huang H-W, Yang C-M, Yang W-S, Yang C-H. Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in Streptozotocin-Induced diabetic rats. PLoS ONE. 2016;11(1):e0146438.","journal-title":"PLoS ONE"},{"key":"778_CR115","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jff.2017.01.023","volume":"31","author":"G Sharavana","year":"2017","unstructured":"Sharavana G, Baskaran V. Lutein downregulates retinal vascular endothelial growth factor possibly via hypoxia inducible factor 1 alpha and X-box binding protein 1 expression in streptozotocin induced diabetic rats. J Funct Foods. 2017;31:97\u2013103.","journal-title":"J Funct Foods"},{"issue":"4","key":"778_CR116","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/jfb14040197","volume":"14","author":"R Arunkumar","year":"2023","unstructured":"Arunkumar R, Baskaran V. Lutein encapsulated in PLGA\u2013Phospholipid Nano-Carrier effectively mitigates cytokines by inhibiting tumor necrosis factor TNF-\u03b1 and nuclear factor NF-\u03baB in mice retina. J Funct Biomater. 2023;14(4):197.","journal-title":"J Funct Biomater"},{"issue":"4","key":"778_CR117","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1080\/15569527.2018.1482494","volume":"37","author":"Y Karakurt","year":"2018","unstructured":"Karakurt Y, U\u00e7ak T, Tasli N, Ahiskali I, \u015eipal S, Kurt N, et al. The effects of lutein on cisplatin-induced retinal injury: an experimental study. Cutan Ocul Toxicol. 2018;37(4):374\u20139.","journal-title":"Cutan Ocul Toxicol"},{"key":"778_CR118","doi-asserted-by":"publisher","first-page":"174014","DOI":"10.1016\/j.ejphar.2021.174014","volume":"899","author":"RE Anitha","year":"2021","unstructured":"Anitha RE, Rajasekar J, Divya P, Vallikannan B. Lactucaxanthin protects retinal pigment epithelium from hyperglycemia-regulated hypoxia\/er stress\/vegf pathway mediated angiogenesis in ARPE-19 cell and rat model. Eur J Pharmacol. 2021;899:174014.","journal-title":"Eur J Pharmacol"},{"key":"778_CR119","doi-asserted-by":"crossref","unstructured":"Hanaguri J, Yokota H, Kushiyama A, Kushiyama S, Watanabe M, Yamagami S et al. Beneficial effect of Long-Term administration of supplement with Trapa Bispinosa roxb. And lutein on retinal neurovascular coupling in type 2 diabetic mice. Front Physiol. 2022;13.","DOI":"10.3389\/fphys.2022.788034"},{"issue":"3","key":"778_CR120","doi-asserted-by":"publisher","first-page":"e12495","DOI":"10.1111\/jfbc.12495","volume":"42","author":"JS Hwang","year":"2018","unstructured":"Hwang JS, Han SG, Lee C-H, Seo HG. Lutein suppresses hyperglycemia-induced premature senescence of retinal pigment epithelial cells by upregulating SIRT1. J Food Biochem. 2018;42(3):e12495.","journal-title":"J Food Biochem"},{"issue":"9","key":"778_CR121","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1258\/ebm.2011.010400","volume":"236","author":"L Tang","year":"2011","unstructured":"Tang L, Zhang Y, Jiang Y, Willard L, Ortiz E, Wark L, et al. Dietary wolfberry ameliorates retinal structure abnormalities in db\/db mice at the early stage of diabetes. Exp Biol Med. 2011;236(9):1051\u201363.","journal-title":"Exp Biol Med"},{"issue":"4","key":"778_CR122","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/antiox6040100","volume":"6","author":"X Gong","year":"2017","unstructured":"Gong X, Draper C, Allison G, Marisiddaiah R, Rubin L. Effects of the macular carotenoid lutein in human retinal pigment epithelial cells. Antioxidants. 2017;6(4):100.","journal-title":"Antioxidants"},{"issue":"5","key":"778_CR123","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/antiox10050753","volume":"10","author":"MB R\u00f3\u017canowska","year":"2021","unstructured":"R\u00f3\u017canowska MB, Czuba-Pelech B, Landrum JT, R\u00f3\u017canowski B. Comparison of antioxidant properties of dehydrolutein with lutein and zeaxanthin, and their effects on cultured retinal pigment epithelial cells. Antioxidants. 2021;10(5):753.","journal-title":"Antioxidants"},{"issue":"2","key":"778_CR124","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12079-019-00539-1","volume":"14","author":"AH Shivarudrappa","year":"2020","unstructured":"Shivarudrappa AH, Ponesakki G. Lutein reverses hyperglycemia-mediated blockage of Nrf2 translocation by modulating the activation of intracellular protein kinases in retinal pigment epithelial (ARPE-19) cells. J Cell Commun Signal. 2020;14(2):207\u201321.","journal-title":"J Cell Commun Signal"},{"key":"778_CR125","doi-asserted-by":"publisher","first-page":"174663","DOI":"10.1016\/j.ejphar.2021.174663","volume":"914","author":"AH Shivarudrappa","year":"2022","unstructured":"Shivarudrappa AH, Kunal Sharan, Ponesakki G. Lutein activates downstream signaling pathways of unfolded protein response in hyperglycemic ARPE-19 cells. Eur J Pharmacol. 2022;914:174663.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"778_CR126","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/nu10070842","volume":"10","author":"M Yu","year":"2018","unstructured":"Yu M, Yan W, Beight C. Lutein and Zeaxanthin isomers protect against Light-Induced retinopathy via decreasing oxidative and Endoplasmic reticulum stress in balb\/cj mice. Nutrients. 2018;10(7):842.","journal-title":"Nutrients"},{"issue":"9","key":"778_CR127","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/jop.2015.0154","volume":"32","author":"C Orhan","year":"2016","unstructured":"Orhan C, Akdemir F, Tuzcu M, Sahin N, Yilmaz I, Deshpande J, et al. Mesozeaxanthin protects retina from oxidative stress in a rat model. J Ocul Pharmacol Ther. 2016;32(9):631\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"15","key":"778_CR128","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.3390\/ijms241512090","volume":"24","author":"X Wang","year":"2023","unstructured":"Wang X, Wang T, Lam E, Alvarez D, Sun Y. Ocular vascular diseases: from retinal immune privilege to inflammation. Int J Mol Sci. 2023;24(15):12090.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"778_CR129","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/cells12020300","volume":"12","author":"RA Kowluru","year":"2023","unstructured":"Kowluru RA. Cross talks between oxidative stress, inflammation and epigenetics in diabetic retinopathy. Cells. 2023;12(2):300.","journal-title":"Cells"},{"issue":"6","key":"778_CR130","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2012.06.024","volume":"53","author":"Q Bian","year":"2012","unstructured":"Bian Q, Gao S, Zhou J, Qin J, Taylor A, Johnson EJ, et al. Lutein and Zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic Biol Med. 2012;53(6):1298\u2013307.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"778_CR131","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1167\/iovs.03-1392","volume":"45","author":"AMA El-Asrar","year":"2004","unstructured":"El-Asrar AMA, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Investig Ophthalmol Vis Sci. 2004;45(8):2760.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"778_CR132","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/bjo.2007.132308","volume":"92","author":"T Oshitari","year":"2008","unstructured":"Oshitari T, Yamamoto S, Hata N, Roy S. Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol. 2008;92(4):552\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"778_CR133","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1167\/iovs.10-6293","volume":"52","author":"AJ Barber","year":"2011","unstructured":"Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Investig Ophthalmol Vis Sci. 2011;52(2):1156.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"778_CR134","doi-asserted-by":"publisher","first-page":"e1218","DOI":"10.1038\/cddis.2014.190","volume":"5","author":"X Zou","year":"2014","unstructured":"Zou X, Gao J, Zheng Y, Wang X, Chen C, Cao K, et al. Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death. Cell Death Dis. 2014;5(5):e1218.","journal-title":"Cell Death Dis"},{"issue":"11","key":"778_CR135","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1167\/iovs.07-0037","volume":"48","author":"AJ Chucair","year":"2007","unstructured":"Chucair AJ, Rotstein NP, Sangiovanni JP, During A, Chew EY, Politi LE. Lutein and Zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Investig Ophthalmol Vis Sci. 2007;48(11):5168.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"778_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/728325","volume":"2012","author":"G Tremolada","year":"2012","unstructured":"Tremolada G, Del Turco C, Lattanzio R, Maestroni S, Maestroni A, Bandello F, et al. The role of angiogenesis in the development of proliferative diabetic retinopathy: impact of intravitreal Anti-VEGF treatment. Exp Diabetes Res. 2012;2012:1\u20138.","journal-title":"Exp Diabetes Res"},{"key":"778_CR137","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.exer.2014.10.016","volume":"133","author":"K Ingeborg","year":"2015","unstructured":"Ingeborg K, Rob JG, Esther JK, Cornelis JFN, Reinier OS. The role of CTGF in diabetic retinopathy. Exp Eye Res. 2015;133:37\u201348.","journal-title":"Exp Eye Res"},{"issue":"4","key":"778_CR138","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1167\/iovs.09-4181","volume":"51","author":"RJ Van Geest","year":"2010","unstructured":"Van Geest RJ, Klaassen I, Vogels IMC, Van Noorden CJF, Schlingemann RO. Differential TGF-\u03b2 signaling in retinal vascular cells: A role in diabetic retinopathy?? Investig Ophthalmol Vis Sci. 2010;51(4):1857.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"778_CR139","first-page":"231","volume":"20","author":"H Wang","year":"2014","unstructured":"Wang H, Zhihong Y, Yanchao J, Elizabeth MH. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2\u2013induced intravitreal neovascularization in a rat model of retinopathy of prematurity. Mol Vis. 2014;20:231\u201341.","journal-title":"Mol Vis"},{"key":"778_CR140","doi-asserted-by":"publisher","first-page":"108104","DOI":"10.1016\/j.exer.2020.108104","volume":"197","author":"G Keegan","year":"2020","unstructured":"Keegan G, Pardhan S, Chichger H. Lutein and Zeaxanthin attenuates VEGF-induced neovascularisation in human retinal microvascular endothelial cells through a Nox4-dependent pathway. Exp Eye Res. 2020;197:108104.","journal-title":"Exp Eye Res"},{"key":"778_CR141","doi-asserted-by":"publisher","first-page":"140","DOI":"10.15761\/NFO.1000132","volume":"2","author":"V Juturu","year":"2016","unstructured":"Juturu V, James P, Bowman, Nicole T, Stringham, Stringhan J. Bioavailability of lutein\/zeaxanthin isomers and macular pigment optical density response to macular carotenoid supplementation: A randomized double blind placebo controlled study. New Front Ophthalmol. 2016;2:140\u20135.","journal-title":"New Front Ophthalmol"},{"issue":"3","key":"778_CR142","first-page":"348","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular Drug Delivery AAPS J. 2010;12(3):348\u201360.","journal-title":"Ocular Drug Delivery AAPS J"},{"key":"778_CR143","doi-asserted-by":"crossref","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023;24(2).","DOI":"10.1208\/s12249-023-02516-9"},{"issue":"3","key":"778_CR144","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","volume":"11","author":"SA Gaballa","year":"2021","unstructured":"Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, et al. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021;11(3):866\u201393.","journal-title":"Drug Deliv Transl Res"},{"issue":"7","key":"778_CR145","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"F Ghasemi","year":"2013","unstructured":"Ghasemi F, Nguyen K. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye. 2013;27(7):787\u201394.","journal-title":"Eye"},{"issue":"1","key":"778_CR146","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/11206721241255721","volume":"35","author":"D Ratra","year":"2025","unstructured":"Ratra D, Murari S, Dalan D, Agarwal V. Immediate response to intravitreal treatment for macular edema due to diabetes and retinal vein occlusion. Eur J Ophthalmol. 2025;35(1):298\u2013305.","journal-title":"Eur J Ophthalmol"},{"key":"778_CR147","doi-asserted-by":"crossref","unstructured":"Wang Z, Zhang N, Lin P, Xing Y, Yang N. Recent advances in the treatment and delivery system of diabetic retinopathy. Front Endocrinol (Lausanne). 2024;15.","DOI":"10.3389\/fendo.2024.1347864"},{"issue":"692","key":"778_CR148","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/pgmj.59.692.343","volume":"59","author":"MA Spiteri","year":"1983","unstructured":"Spiteri MA, James DG. Adverse ocular reactions to drugs. Postgrad Med J. 1983;59(692):343\u20139.","journal-title":"Postgrad Med J"},{"issue":"1","key":"778_CR149","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1556-276X-9-247","volume":"9","author":"E Abbasi","year":"2014","unstructured":"Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 2014;9(1):247.","journal-title":"Nanoscale Res Lett"},{"key":"778_CR150","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejpb.2015.05.016","volume":"95","author":"K Susanne","year":"2015","unstructured":"Susanne K, Achim MG, Ferdinand PB. Hydrogels in ophthalmic applications. Eur J Pharm Biopharm. 2015;95:227\u201338.","journal-title":"Eur J Pharm Biopharm"},{"key":"778_CR151","doi-asserted-by":"crossref","unstructured":"Hussain A-M, Mohammed, Imad HH. Hydrogels and nanogels as a promising carrier for drug delivery. Hydrogels and Nanogels - Applications in Medicine: IntechOpen;; 2023.","DOI":"10.5772\/intechopen.1002417"},{"issue":"8","key":"778_CR152","doi-asserted-by":"publisher","first-page":"e0306640","DOI":"10.1371\/journal.pone.0306640","volume":"19","author":"RT Carter","year":"2024","unstructured":"Carter RT, Swetledge S, Navarro S, Liu C-C, Ineck N, Lewin AC, et al. The impact of lutein-loaded poly(lactic-co-glycolic acid) nanoparticles following topical application: an in vitro and in vivo study. PLoS ONE. 2024;19(8):e0306640.","journal-title":"PLoS ONE"},{"issue":"2","key":"778_CR153","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12247-021-09537-6","volume":"17","author":"S Sunny","year":"2022","unstructured":"Sunny S, Bhanderi B, Soniwala M, Chavda J. Lutein-Loaded solid lipid nanoparticles for ocular delivery: statistical optimization and ex vivo evaluation. J Pharm Innov. 2022;17(2):584\u201398.","journal-title":"J Pharm Innov"},{"key":"778_CR154","doi-asserted-by":"crossref","unstructured":"Chittasupho C, Posritong P, Ariyawong P. Stability, cytotoxicity, and retinal pigment epithelial cell binding of hyaluronic Acid-Coated PLGA nanoparticles encapsulating lutein. AAPS PharmSciTech. 2019;20(1).","DOI":"10.1208\/s12249-018-1256-0"},{"key":"778_CR155","doi-asserted-by":"publisher","first-page":"124378","DOI":"10.1016\/j.ijbiomac.2023.124378","volume":"240","author":"V Toragall","year":"2023","unstructured":"Toragall V, Muzaffar JC, Baskaran V. Lutein loaded double-layered polymer nanocarrier modulate H2O2 and CoCl2 induced oxidative and hypoxia damage and angiogenic markers in ARPE-19 cells. Int J Biol Macromol. 2023;240:124378.","journal-title":"Int J Biol Macromol"},{"key":"778_CR156","doi-asserted-by":"publisher","first-page":"117409","DOI":"10.1016\/j.carbpol.2020.117409","volume":"254","author":"V Toragall","year":"2021","unstructured":"Toragall V, Vallikanan B. Chitosan-sodium alginate-fatty acid nanocarrier system: lutein bioavailability, absorption pharmacokinetics in diabetic rat and protection of retinal cells against H2O2 induced oxidative stress in vitro. Carbohydr Polym. 2021;254:117409.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"778_CR157","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.exer.2007.09.010","volume":"86","author":"NM Kalariya","year":"2008","unstructured":"Kalariya NM, Ramana KV, Srivastava SK, Van Kuijk FJGM. Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells. Exp Eye Res. 2008;86(1):70\u201380.","journal-title":"Exp Eye Res"},{"key":"778_CR158","first-page":"2517","volume":"9","author":"J Lou","year":"2014","unstructured":"Lou J, Wenjing H, Tian R, Zhang H, Jia Y, Zhang J, et al. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles. Int J Nanomed. 2014;9:2517\u201325.","journal-title":"Int J Nanomed"},{"issue":"4","key":"778_CR159","first-page":"469","volume":"28","author":"A Salimi","year":"2022","unstructured":"Salimi A, Sharif Makhmalzadeh B, Feghhi M, Rezai A, Bagheri F. Evaluation of the effect of naringenin liposomal formulation on retinopathy in an experimental rabbit model. Kafkas Univ Vet Fak Derg. 2022;28(4):469\u201379.","journal-title":"Kafkas Univ Vet Fak Derg"},{"key":"778_CR160","doi-asserted-by":"publisher","first-page":"121451","DOI":"10.1016\/j.ijpharm.2022.121451","volume":"615","author":"Y Li","year":"2022","unstructured":"Li Y, Lei Z, Mengmeng Z, Runzhi L, Guohu D, Hongyun L, et al. Micelles based on Polyvinylpyrrolidone VA64: A potential nanoplatform for the ocular delivery of Apocynin. Int J Pharm. 2022;615:121451.","journal-title":"Int J Pharm"},{"key":"778_CR161","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejpb.2015.02.006","volume":"92","author":"GR Adelli","year":"2015","unstructured":"Adelli GR, Hingorani T, Punyamurthula N, Balguri SP, Majumdar S. Evaluation of topical Hesperetin matrix film for back-of-the-eye delivery. Eur J Pharm Biopharm. 2015;92:74\u201382.","journal-title":"Eur J Pharm Biopharm"},{"key":"778_CR162","doi-asserted-by":"publisher","first-page":"105289","DOI":"10.1016\/j.ejps.2020.105289","volume":"147","author":"F Zhang","year":"2020","unstructured":"Zhang F, Rong L, Meixin Y, Qiqi L, Yaru L, Xianggen W. Ultra-small nanocomplexes based on Polyvinylpyrrolidone K-17PF: A potential nanoplatform for the ocular delivery of Kaempferol. Eur J Pharm Sci. 2020;147:105289.","journal-title":"Eur J Pharm Sci"},{"key":"778_CR163","doi-asserted-by":"publisher","first-page":"119133","DOI":"10.1016\/j.ijpharm.2020.119133","volume":"578","author":"H Wang","year":"2020","unstructured":"Wang H, Xuefei L, Hui Y, Jun W, Qiqi L, Ruijing Q, et al. Nanocomplexes based Polyvinylpyrrolidone K-17PF for ocular drug delivery of naringenin. Int J Pharm. 2020a;578:119133.","journal-title":"Int J Pharm"},{"key":"778_CR164","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ijbiomac.2020.09.234","volume":"165","author":"SB Florencia","year":"2020","unstructured":"Florencia SB, Agustina A, Mariana CDS, Fernanda E, Guadalupe GL, Sof\u00eda LA, et al. Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: impact on human ARPE-19 culture cells. Int J Biol Macromol. 2020;165:804\u201321.","journal-title":"Int J Biol Macromol"},{"key":"778_CR165","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijbiomac.2015.11.070","volume":"84","author":"SB Da Silva","year":"2016","unstructured":"Da Silva SB, Ferreira D, Pintado M, Sarmento B. Chitosan-based nanoparticles for Rosmarinic acid ocular delivery\u2014In vitro tests. Int J Biol Macromol. 2016;84:112\u201320.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"778_CR166","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3390\/pharmaceutics14091961","volume":"14","author":"E Zingale","year":"2022","unstructured":"Zingale E, Rizzo S, Bonaccorso A, Consoli V, Vanella L, Musumeci T, et al. Optimization of lipid nanoparticles by response surface methodology to improve the ocular delivery of diosmin: characterization and In-Vitro Anti-Inflammatory assessment. Pharmaceutics. 2022;14(9):1961.","journal-title":"Pharmaceutics"},{"issue":"4","key":"778_CR167","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/molecules27041328","volume":"27","author":"D Santonocito","year":"2022","unstructured":"Santonocito D, Vivero-Lopez M, Lauro MR, Torrisi C, Castelli F, Sarpietro MG, et al. Design of Nanotechnological carriers for ocular delivery of mangiferin: preformulation study. Molecules. 2022;27(4):1328.","journal-title":"Molecules"},{"issue":"7","key":"778_CR168","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/pharmaceutics11070297","volume":"11","author":"D Kim","year":"2019","unstructured":"Kim D, Pooja M, Minki J, Taehoon P, Anjila M, Reeju A, et al. Potential Albumin-Based antioxidant nanoformulations for ocular protection against oxidative stress. Pharmaceutics. 2019;11(7):297.","journal-title":"Pharmaceutics"},{"issue":"5","key":"778_CR169","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/pharmaceutics13050687","volume":"13","author":"A Romeo","year":"2021","unstructured":"Romeo A, Musumeci T, Carbone C, Bonaccorso A, Corvo S, Lupo G, et al. Ferulic Acid-Loaded polymeric nanoparticles for potential ocular delivery. Pharmaceutics. 2021;13(5):687.","journal-title":"Pharmaceutics"},{"issue":"9","key":"778_CR170","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/pharmaceutics12090798","volume":"12","author":"PK Bolla","year":"2020","unstructured":"Bolla PK, Gote V, Singh M, Patel M, Clark BA, Renukuntla J. Lutein-Loaded, Biotin-Decorated polymeric nanoparticles enhance lutein uptake in retinal cells. Pharmaceutics. 2020;12(9):798.","journal-title":"Pharmaceutics"},{"issue":"16","key":"778_CR171","doi-asserted-by":"publisher","first-page":"1700264","DOI":"10.1002\/adhm.201700264","volume":"6","author":"S Kyle","year":"2017","unstructured":"Kyle S, Jessop ZM, Al-Sabah A, Whitaker IS. Printability\u2019 of candidate biomaterials for extrusion based 3D printing: State\u2010of\u2010the\u2010Art. Adv Healthc Mater. 2017;6(16):1700264.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"778_CR172","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/polym12102262","volume":"12","author":"AS Theus","year":"2020","unstructured":"Theus AS, Ning L, Hwang B, Gil C, Chen S, Wombwell A, et al. Bioprintability: physiomechanical and biological requirements of materials for 3D Bioprinting processes. Polymers. 2020;12(10):2262.","journal-title":"Polymers"},{"issue":"2","key":"778_CR173","doi-asserted-by":"publisher","first-page":"552","DOI":"10.18063\/ijb.v8i2.552","volume":"8","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang J, Ji Z, Yan W, Zhao H, Huang W, et al. Application of Bioprinting in ophthalmology. Int J Bioprinting. 2022;8(2):552.","journal-title":"Int J Bioprinting"},{"issue":"19","key":"778_CR174","doi-asserted-by":"publisher","first-page":"11488","DOI":"10.1021\/acs.chemrev.3c00290","volume":"123","author":"S Hunkyu","year":"2023","unstructured":"Hunkyu S, Won GC, Yong WK, Sumin K, Yeon-Mi H, Wonjung P, et al. Smart contact lenses as wearable ophthalmic devices for disease monitoring and health management. Chem Rev. 2023;123(19):11488\u2013558.","journal-title":"Chem Rev"},{"issue":"3","key":"778_CR175","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0110-5558.72419","volume":"1","author":"A Kumari","year":"2010","unstructured":"Kumari A, Sharma PK, Garg VK, Garg G. Ocular inserts \u2014 Advancement in therapy of eye diseases. J Adv Pharm Technol Res. 2010;1(3):291\u20136.","journal-title":"J Adv Pharm Technol Res"},{"key":"778_CR176","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jconrel.2018.05.020","volume":"281","author":"J Xu","year":"2018","unstructured":"Xu J, Yingyan X, Hu G, Lin T, Gou J, Yin T, et al. A comprehensive review on contact lens for ophthalmic drug delivery. J CAdvanced Healthc Materialsontrolled Release. 2018;281:97\u2013118.","journal-title":"J CAdvanced Healthc Materialsontrolled Release"},{"issue":"5","key":"778_CR177","doi-asserted-by":"publisher","first-page":"728","DOI":"10.5301\/ejo.5000444","volume":"24","author":"C Cagini","year":"2014","unstructured":"Cagini C, Caricato A, Tosi G, Pascale A, Cesari C, Fiore T. Evaluation of the efficacy and safety of the ophthalmic insert mydriasert in patients undergoing retinal angiography - PubMed. Eur J Ophthalmol. 2014;24(5):728\u201334.","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"778_CR178","first-page":"683","volume":"12","author":"RR Joseph","year":"2017","unstructured":"Joseph RR, Venkatraman SS. Drug delivery to the eye: what benefits do. Nanocarriers Offer?? Nanomed. 2017;12(6):683\u2013702.","journal-title":"Nanocarriers Offer?? Nanomed"},{"issue":"1","key":"778_CR179","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/pharmaceutics15010243","volume":"15","author":"F Annuryanti","year":"2023","unstructured":"Annuryanti F, Dom\u00ednguez-Robles J, Anjani QK, Adrianto MF, Larra\u00f1eta E, Thakur RRS. Fabrication and characterisation of 3D-Printed triamcinolone Acetonide-Loaded Polycaprolactone-Based ocular implants. Pharmaceutics. 2023;15(1):243.","journal-title":"Pharmaceutics"},{"key":"778_CR180","doi-asserted-by":"publisher","first-page":"105353","DOI":"10.1016\/j.jddst.2024.105353","volume":"92","author":"G Duman","year":"2024","unstructured":"Duman G, \u0130pek Y\u0131ld\u0131r, Macit M, Gen\u00e7 E, S\u00fcmer E, Kale S, et al. Development and evaluation of 3D-printed ocular insert containing liposomal Moxifloxacin. J Drug Deliv Sci Technol. 2024;92:105353.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"778_CR181","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/pharmaceutics13091421","volume":"13","author":"X Xu","year":"2021","unstructured":"Xu X, Awwad S, Diaz-Gomez L, Alvarez-Lorenzo C, Brocchini S, Gaisford S, et al. 3D printed punctal plugs for controlled ocular drug delivery. Pharmaceutics. 2021;13(9):1421.","journal-title":"Pharmaceutics"},{"key":"778_CR182","doi-asserted-by":"publisher","first-page":"133636","DOI":"10.1016\/j.matlet.2022.133636","volume":"333","author":"G Mayank","year":"2023","unstructured":"Mayank G, Rajkumar S, Gopinath P. Viability studies of hydrogel contact lens on a 3D printed platform as ocular drug delivery carrier for diabetic retinopathy. Mater Lett. 2023;333:133636.","journal-title":"Mater Lett"},{"issue":"2","key":"778_CR183","first-page":"138","volume":"3","author":"S Pujiang","year":"2017","unstructured":"Pujiang S, Tan YSE, Wai YY, Augustinus L. Hybrid three-dimensional (3D) Bioprinting of retina equivalent for ocular research. Int J Bioprinting. 2017;3(2):138\u201346.","journal-title":"Int J Bioprinting"},{"key":"778_CR184","doi-asserted-by":"crossref","unstructured":"Liu H, Chushan W, Shiyin H, Bin L, Xiaowei L, Zengping L et al. Lutein modulates cellular functionalities and regulates NLRP3 inflammasome in a H2O2-Challenged Three-Dimensional retinal pigment epithelium model. J Agric Food Chem. 2024;72(26).","DOI":"10.1021\/acs.jafc.4c01537"},{"key":"778_CR185","doi-asserted-by":"crossref","unstructured":"Allyn MM, Luo RH, Hellwarth EB, Swindle-Reilly KE. Considerations for polymers used in ocular drug delivery. Front Med. 2022;8.","DOI":"10.3389\/fmed.2021.787644"},{"issue":"6","key":"778_CR186","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.3390\/pharmaceutics15061746","volume":"15","author":"M Mostafa","year":"2023","unstructured":"Mostafa M, Al Fatease A, Alany RG, Abdelkader H. Recent advances of ocular drug delivery systems: prominence of ocular implants for chronic eye diseases. Pharmaceutics. 2023;15(6):1746.","journal-title":"Pharmaceutics"},{"issue":"7958","key":"778_CR187","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov AV, Katritch V. Computational approaches streamlining drug discovery. Nature. 2023;616(7958):673\u201385.","journal-title":"Nature"},{"issue":"9","key":"778_CR188","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","volume":"44","author":"FW Pun","year":"2023","unstructured":"Pun FW, Ozerov IV, Zhavoronkov A. AI-powered therapeutic target discovery. Trends Pharmacol Sci. 2023;44(9):561\u201372.","journal-title":"Trends Pharmacol Sci"},{"key":"778_CR189","doi-asserted-by":"publisher","first-page":"108950","DOI":"10.1016\/j.jmgm.2025.108950","volume":"136","author":"T Li","year":"2025","unstructured":"Li T, Ma B, Zhang L, Wang M. Glipizide inhibits the glycation of alpha-crystallin: A combined in vitro and in Silico approach in retinopathy management. J Mol Graph Model. 2025;136:108950.","journal-title":"J Mol Graph Model"},{"issue":"12","key":"778_CR190","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.3390\/biomedicines11123202","volume":"11","author":"HMF Mohammad","year":"2023","unstructured":"Mohammad HMF, Eladl MA, Abdelmaogood AKK, Elshaer RE, Ghanam W, Elaskary A, et al. Protective effect of topiramate against diabetic retinopathy and computational approach recognizing the role of NLRP3\/IL-1\u03b2\/TNF-\u03b1 signaling. Biomedicines. 2023;11(12):3202.","journal-title":"Biomedicines"},{"issue":"1","key":"778_CR191","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, et al. Molecular Docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep. 2023;13(1):13398.","journal-title":"Sci Rep"},{"issue":"11","key":"778_CR192","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u201390.","journal-title":"Nat Chem Biol"},{"issue":"9","key":"778_CR193","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/biology13090732","volume":"13","author":"N Sahu","year":"2024","unstructured":"Sahu N, Tyagi R, Kumar N, Mujeeb M, Akhtar A, Alam P, et al. Forecasting the Pharmacological mechanisms of Plumbago Zeylanica and solanum xanthocarpum in diabetic retinopathy treatment: A network pharmacology, molecular docking, and molecular dynamics simulation study. Biology. 2024;13(9):732.","journal-title":"Biology"},{"key":"778_CR194","doi-asserted-by":"crossref","unstructured":"Zhou Y, Shu F, Sarsaiya S, Jiang H, Jiang C, Qu T et al. Network Pharmacology and molecular Docking to explore Siraitia grosvenorii\u2019s potential mechanism in preventing and treating proliferative diabetic retinopathy. Front Drug Discov. 2022;2.","DOI":"10.3389\/fddsv.2022.1038224"},{"key":"778_CR195","doi-asserted-by":"crossref","unstructured":"Qi Jin X-F, Hao L-K, Xie J, Xu M, Sun H, Yuan et al. A network Pharmacology to explore the mechanism of astragalus Membranaceus in the treatment of diabetic retinopathy. Evid Based Complement Alternat Med. 2020;2020(1).","DOI":"10.1155\/2020\/8878569"},{"issue":"1","key":"778_CR196","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1386207325666220407112018","volume":"26","author":"S He","year":"2023","unstructured":"He S, Gu C, Su T, Zhou C, Lhamo T, Draga D, et al. Exploration of the potential mechanisms of Lingqihuangban granule for treating diabetic retinopathy based on network Pharmacology. Comb Chem High Throughput Screen. 2023;26(1):14\u201329.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"1","key":"778_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2896185","volume":"2022","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Fan G, Zhang Y, Xu L. Identification of potential molecular targets and active ingredients of Mingmu Dihuang pill for the treatment of diabetic retinopathy based on network Pharmacology. Biomed Res Int. 2022;2022(1):1\u201318.","journal-title":"Biomed Res Int"},{"key":"778_CR198","doi-asserted-by":"crossref","unstructured":"Chunli P, Zheyu S, De J, Han W, Xuemin W, Naiwen Z et al. Network Pharmacology-based investigation of the underlying mechanism of Panax Notoginseng treatment of diabetic retinopathy. Comb Chem High Throughput Screen. 2020;23(4).","DOI":"10.2174\/1386207323666200305093709"},{"key":"778_CR199","doi-asserted-by":"crossref","unstructured":"Zhang M, Yang J, Zhao X, Zhao Y, Zhu S. Network Pharmacology and molecular Docking study on the active ingredients of Qidengmingmu capsule for the treatment of diabetic retinopathy. Sci Rep. 2021;11(1).","DOI":"10.1038\/s41598-021-86914-8"},{"key":"778_CR200","doi-asserted-by":"crossref","unstructured":"Piao C-L, Luo J-L, Jin D, Tang C, Wang L, Lian F-M et al. Utilizing network Pharmacology to explore the underlying mechanism of radix salviae in diabetic retinopathy. Chin Med. 2019;14(1).","DOI":"10.1186\/s13020-019-0280-7"},{"issue":"1","key":"778_CR201","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1080\/13880209.2021.1979051","volume":"59","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xue B, Wang X, Wang Q, Liu E, Chen X. Pharmacokinetic study of Tangwang Mingmu granule for the management of diabetic retinopathy based on network Pharmacology. Pharm Biol. 2021;59(1):1332\u201348.","journal-title":"Pharm Biol"},{"issue":"1","key":"778_CR202","first-page":"1","volume":"2020","author":"H Li","year":"2020","unstructured":"Li H, Li B, Zheng Y. Exploring the mechanism of action Compound-Xueshuantong capsule in diabetic retinopathy treatment based on network Pharmacology. Evid Based Complement Alternat Med. 2020;2020(1):1\u201312.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"778_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3528732","volume":"2022","author":"X Man","year":"2022","unstructured":"Man X, Sai Z. Study on the prognosis effect of traditional Chinese medicine treatment in DR patients based on the perspective of network Pharmacology. Contrast Media Mol Imaging. 2022;2022(1):1\u20138.","journal-title":"Contrast Media Mol Imaging"},{"key":"778_CR204","doi-asserted-by":"crossref","unstructured":"T\u00fcrke\u015f C, Demir Y, Beydemir \u015e. In Vitro Inhibitory Activity and Molecular Docking Study of Selected Natural Phenolic Compounds as AR and SDH Inhibitors**. ChemistrySelect. 2022;7(48).","DOI":"10.1002\/slct.202204050"},{"key":"778_CR205","doi-asserted-by":"publisher","first-page":"108281","DOI":"10.1016\/j.compbiolchem.2024.108281","volume":"114","author":"BC Arvind","year":"2025","unstructured":"Arvind BC, Hemamalini K, Babitha B, Yogendra KV, Mahendra KV. In-silico study and in-vitro validations for an affinity of mangiferin with aldose reductase: investigating potential in tackling diabetic retinopathy. Comput Biol Chem. 2025;114:108281.","journal-title":"Comput Biol Chem"},{"key":"778_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9624118","volume":"2022","author":"A Julius","year":"2022","unstructured":"Julius A, Renuka RR, Hopper W, Babu Raghu P, Rajendran S, Srinivasan S, et al. Inhibition of aldose reductase by novel phytocompounds: A heuristic approach to treating diabetic retinopathy. Evid Based Complement Alternat Med. 2022;2022:1\u201310.","journal-title":"Evid Based Complement Alternat Med"},{"key":"778_CR207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3412032","volume":"2022","author":"Y Ren","year":"2022","unstructured":"Ren Y, Liu Y, Liu K, Huo X, Liu C, Zhang Y. Discovery of therapeutic candidates for diabetic retinopathy based on molecular switch analysis: application of a systematic process. Oxid Med Cell Longev. 2022;2022:1\u201320.","journal-title":"Oxid Med Cell Longev"},{"key":"778_CR208","doi-asserted-by":"publisher","first-page":"175215","DOI":"10.1016\/j.ejphar.2022.175215","volume":"931","author":"C Liu","year":"2022","unstructured":"Liu C, Ren Y, Sui X, Liu K, Zhang J, Wang Z, et al. Integrating network pharmacology, transcriptomics, and molecular simulation to reveal the mechanism of tert-butylhydroquinone for treating diabetic retinopathy. Eur J Pharmacol. 2022;931:175215.","journal-title":"Eur J Pharmacol"},{"key":"778_CR209","doi-asserted-by":"publisher","first-page":"e24008","DOI":"10.53388\/IMD202408008","volume":"8","author":"YY Gan","year":"2024","unstructured":"Gan YY, Xu YM, Shu Q. Exploring the molecular mechanism of action of Curcumin for the treatment of diabetic retinopathy, using network pharmacology, molecular docking, and molecular dynamics simulation. Integr Med Discov. 2024;8:e24008.","journal-title":"Integr Med Discov"},{"key":"778_CR210","doi-asserted-by":"publisher","first-page":"101424","DOI":"10.1016\/j.bcab.2019.101424","volume":"22","author":"AS Lutfiya","year":"2019","unstructured":"Lutfiya AS, Priya S, Manzoor MAP, Hemalatha S. Molecular Docking and interactions between vascular endothelial growth factor (VEGF) receptors and phytochemicals: an in-silico study. Biocatal Agric Biotechnol. 2019;22:101424.","journal-title":"Biocatal Agric Biotechnol"},{"issue":"24","key":"778_CR211","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1080\/07391102.2023.2276880","volume":"42","author":"A Thottappillil","year":"2024","unstructured":"Thottappillil A, Sahoo S, Chakraborty A, Kouser S, Ravi V, Garawadmath S, et al. In vitro and in Silico analysis proving DPP4 Inhibition and diabetes-associated gene network modulation by a polyherbal formulation: Nisakathakadi Kashaya. J Biomol Struct Dyn. 2024;42(24):13588\u2013602.","journal-title":"J Biomol Struct Dyn"},{"issue":"11","key":"778_CR212","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1080\/07391102.2023.2227720","volume":"42","author":"A Firoz","year":"2024","unstructured":"Firoz A, Talwar P. Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an in-silico approach towards therapeutic intervention. J Biomol Struct Dyn. 2024;42(11):5686\u201398.","journal-title":"J Biomol Struct Dyn"},{"key":"778_CR213","doi-asserted-by":"crossref","unstructured":"Liu J, Li X, Cheng Y, Liu K, Zou H, You Z. Identification of potential ferroptosis-related biomarkers and a pharmacological compound in diabetic retinopathy based on machine learning and molecular docking. Front Endocrinol (Lausanne). 2022;13.","DOI":"10.3389\/fendo.2022.988506"},{"key":"778_CR214","doi-asserted-by":"crossref","unstructured":"Cui J, Shi E, Wang Y, Liu T. Network Pharmacology study of the mechanism underlying the therapeutic effect of Zhujing pill and its main component oleanolic acid against diabetic retinopathy. Biosci Rep. 2023;43(1).","DOI":"10.1042\/BSR20220893"},{"key":"778_CR215","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bcp.2018.09.016","volume":"158","author":"BMP Chiara","year":"2018","unstructured":"Chiara BMP, Gian ML, Filippo D, Salvatore S, Claudio B. Computational systems biology approach to identify novel Pharmacological targets for diabetic retinopathy. Biochem Pharmacol. 2018;158:13\u201326.","journal-title":"Biochem Pharmacol"},{"key":"778_CR216","doi-asserted-by":"crossref","unstructured":"Kumari N, Karmakar A, Chakrabarti S, Ganesan SK. Integrative computational approach revealed crucial genes associated with different stages of diabetic retinopathy. Front Genet. 2020;11.","DOI":"10.3389\/fgene.2020.576442"},{"key":"778_CR217","doi-asserted-by":"publisher","first-page":"147339","DOI":"10.1016\/j.gene.2023.147339","volume":"866","author":"TS Dipanka","year":"2023","unstructured":"Dipanka TS, Sunil G, Santosh M, Nandadulal B, Samrat C. Identification of critical autophagy-related proteins in diabetic retinopathy: A multi-dimensional computational study. Gene. 2023;866:147339.","journal-title":"Gene"},{"issue":"7","key":"778_CR218","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/bjo-2023-323639","volume":"108","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Huang W, Tian Q, Bai G, Wu W, Yin H, et al. Network Pharmacology and biochemical experiments reveal the antiapoptotic mechanism of huperzine A for treating diabetic retinopathy. Br J Ophthalmol. 2024;108(7):989\u201398.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"778_CR219","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13273-021-00167-0","volume":"18","author":"J Jiang","year":"2022","unstructured":"Jiang J, Che X, Qian Y, Lu S, Wang Z. Myricitrin exerts protective effect on retina in diabetic retinopathy via modulating oxidative stress expression of VEGF and apoptosis in experimental rats: a Docking confirmation study. Mol Cell Toxicol. 2022;18(2):149\u201358.","journal-title":"Mol Cell Toxicol"},{"issue":"20","key":"778_CR220","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.6026\/97320630091040","volume":"9","author":"SV Gogula","year":"2013","unstructured":"Gogula SV, Divakar C, Satyanarayana C, Kumar YP, Lavanaya VS. Computational investigation of Pkc\u03b2 inhibitors for the treatment of diabetic retinopathy. Bioinformation. 2013;9(20):1040\u20133.","journal-title":"Bioinformation"},{"issue":"1","key":"778_CR221","first-page":"nzz031","volume":"3","author":"S Swetha","year":"2019","unstructured":"Swetha S, Kerry G. Molecular Docking interaction between carotenoids and Curcumin and RAGE receptor prevents diabetic retinopathy progression (P06-044-19). Curr Dev Nutr. 2019;3(1):nzz031\u2013P006.","journal-title":"Curr Dev Nutr"},{"issue":"4","key":"778_CR222","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/APO.0000000000000071","volume":"3","author":"P Srivastava","year":"2014","unstructured":"Srivastava P, Tiwari A, Trivedi AC, Thakur V, Pant AB, Saxena S. Virtual screening of natural and synthetic ligands against diabetic retinopathy by molecular interaction with Angiopoietin-2. Asia-Pac J Ophthalmol. 2014;3(4):257\u20139.","journal-title":"Asia-Pac J Ophthalmol"},{"key":"778_CR223","unstructured":"Bai W, Qin J. Network Pharmacology analysis of Ginkgo leaves extract against diabetic retinopathy. CJEO. 2022:813\u20139."},{"issue":"3","key":"778_CR224","doi-asserted-by":"publisher","first-page":"99","DOI":"10.33435\/tcandtc.1396721","volume":"8","author":"M Aswad","year":"2024","unstructured":"Aswad M, Nugraha R, Yulianty R. Potency of bisindoles from Caulerpa racemosa in handling Diabetes-Related complications: in Silico ADMET properties and molecular Docking simulations. Turkish Comp Theo Chem. 2024;8(3):99\u2013107.","journal-title":"Turkish Comp Theo Chem"},{"issue":"8","key":"778_CR225","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/bioengineering10080983","volume":"10","author":"F Bodea","year":"2023","unstructured":"Bodea F, Bungau SG, Negru AP, Radu A, Tarce AG, Tit DM, et al. Exploring new therapeutic avenues for ophthalmic disorders: Glaucoma-Related molecular Docking evaluation and bibliometric analysis for improved management of ocular diseases. Bioengineering. 2023;10(8):983.","journal-title":"Bioengineering"},{"key":"778_CR226","doi-asserted-by":"crossref","unstructured":"Alagarsamy V, Sulthana MT, Solomon VR, Satishchandra A, Kulkarni VS, Narendhar B et al. Identification of potential inhibitors from medicinal Plant-based phytochemicals for the influential C4 target of diabetic retinopathy by molecular Docking studies. Curr Pharm Des. 2024;31(4).","DOI":"10.2174\/0113816128297758240723104452"},{"key":"778_CR227","doi-asserted-by":"crossref","unstructured":"Alagarsamy V, Sulthana MT, Solomon VR, Satishchandra A, Kulkarni VS, Narendhar B et al. Molecular Docking and in Silico ADME(T) evaluation of selective phytochemical inhibitors of VEGF2 target for the treatment of diabetic retinopathy. Curr Chem Biol. 2024;18(3).","DOI":"10.2174\/0122127968307102241007054913"},{"issue":"6","key":"778_CR228","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/17460441.2024.2349149","volume":"19","author":"AA Victor","year":"2024","unstructured":"Victor AA, Kushal K, Hung ND, Jinan W, Yinglong M. Understanding the impact of binding free energy and kinetics calculations in modern drug discovery. Expert Opin Drug Discov. 2024;19(6):671\u201382.","journal-title":"Expert Opin Drug Discov"},{"issue":"5","key":"778_CR229","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/molecules23051038","volume":"23","author":"R David","year":"2018","unstructured":"David R, Julio C, Ram\u00edrez D, Caballero J. Is it reliable to take the molecular Docking top scoring position as the best solution without considering available structural data?? Molecules. 2018;23(5):1038.","journal-title":"Molecules"},{"issue":"1","key":"778_CR230","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1038\/s41467-024-49858-x","volume":"15","author":"S Xintao","year":"2024","unstructured":"Xintao S, Lei B, Chenjie F, Qiang H, Fa Z, Xin G, et al. Accurate prediction of protein structural flexibility by deep learning integrating intricate atomic structures and Cryo-EM density information. Nat Commun. 2024;15(1):5538.","journal-title":"Nat Commun"},{"issue":"5","key":"778_CR231","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"G Samuel","year":"2015","unstructured":"Samuel G, Ulf R. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449\u201361.","journal-title":"Expert Opin Drug Discov"},{"key":"778_CR232","doi-asserted-by":"crossref","unstructured":"Bunker A, R\u00f3g T. Mechanistic Understanding from molecular dynamics simulation in pharmaceutical research 1: drug delivery. Front Mol Biosci. 2020;7.","DOI":"10.3389\/fmolb.2020.604770"},{"key":"778_CR233","doi-asserted-by":"crossref","unstructured":"Paul JM, Ramesh S. Physiologically based ocular Pharmacokinetic modeling using computational methods. Drug Discov Today. 2019;24(8).","DOI":"10.1016\/j.drudis.2019.05.039"},{"key":"778_CR234","doi-asserted-by":"crossref","unstructured":"Madden JC, Thompson CV. Pharmacokinetic tools and applications. Methods mol biol. Springer US; 2022. pp. 57\u201383.","DOI":"10.1007\/978-1-0716-1960-5_3"},{"key":"778_CR235","doi-asserted-by":"crossref","unstructured":"Tim UK, Nicole E, Frank GH, Carsten HM. Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans. Am J Ophthalmol. 2008;146(4).","DOI":"10.1016\/j.ajo.2008.05.036"},{"key":"778_CR236","doi-asserted-by":"crossref","unstructured":"Tim UK, Zengping L, Frank GH, Carsten HM. Intraocular pharmacokinetics of Ranibizumab following a single intravitreal injection in humans. Am J Ophthalmol. 2012;154(4).","DOI":"10.1016\/j.ajo.2012.03.047"},{"key":"778_CR237","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ces.2014.01.005","volume":"108","author":"EK Michail","year":"2014","unstructured":"Michail EK, Nikolaos GK, Dimitrios TH. Computational modeling of drug delivery to the posterior eye. Chem Eng Sci. 2014;108:203\u201312.","journal-title":"Chem Eng Sci"},{"issue":"17","key":"778_CR238","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1055\/a-0947-5712","volume":"85","author":"M-S Isabel","year":"2019","unstructured":"Isabel M-S, Nuria A, Francisco B-M, Encarna C, Mar\u00eda EG-R, Dolores M-M, et al. Neuroprotective potential of Ginkgo Biloba in retinal diseases. Planta Med. 2019;85(17):1292\u2013303.","journal-title":"Planta Med"},{"issue":"4","key":"778_CR239","doi-asserted-by":"publisher","first-page":"301","DOI":"10.14341\/DM8212","volume":"20","author":"G Selvaraj","year":"2017","unstructured":"Selvaraj G, Kaliamurthi S, Elibol \u00c7akmak Z, \u00c7akmak T. In Silico validation of microalgal metabolites against diabetes mellitus. Diabetes Mellitus. 2017;20(4):301\u20137.","journal-title":"Diabetes Mellitus"},{"issue":"1","key":"778_CR240","doi-asserted-by":"publisher","first-page":"15","DOI":"10.51511\/pr.15","volume":"1","author":"IGB Krisnayana","year":"2021","unstructured":"Krisnayana IGB, Febyani PD, Sari IAYP, Laksmiani NPL. Molecular Docking of lutein as anti-photoaging agent in Silico. Pharm Rep. 2021;1(1):15.","journal-title":"Pharm Rep"},{"issue":"11","key":"778_CR241","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1039\/D1FO04064B","volume":"13","author":"N Shamarao","year":"2022","unstructured":"Shamarao N, Chethankumar M. Antiobesity drug-likeness properties and pancreatic lipase Inhibition of a novel low molecular weight lutein oxidized product, LOP6. Food Funct. 2022;13(11):6036\u201355.","journal-title":"Food Funct"},{"issue":"3","key":"778_CR242","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/scipharm92030049","volume":"92","author":"V Anjum","year":"2024","unstructured":"Anjum V, Bagale U, Kadi A, Potoroko I. A network Pharmacology and molecular Docking technology to identify and explore mechanism of bioactive components of fucus vesiculosus against gut disorders. Sci Pharm. 2024;92(3):49.","journal-title":"Sci Pharm"},{"issue":"1","key":"778_CR243","doi-asserted-by":"publisher","first-page":"17","DOI":"10.51511\/pr.17","volume":"1","author":"NKN Cahyani","year":"2021","unstructured":"Cahyani NKN, Putri WNE, Dwivayana IKD, Mirayanti NPD, Laksmiani NPL. In Silico study of lutein as anti-HER-2 receptors in breast cancer treatment. Pharm Rep. 2021;1(1):17.","journal-title":"Pharm Rep"},{"issue":"7","key":"778_CR244","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","volume":"140","author":"E Chew","year":"2022","unstructured":"Chew E, Clemons T, Agr\u00f3n E, Domalpally A, Keenan T, Vitale S, et al. Long-term outcomes of adding lutein\/zeaxanthin and \u03c9-3 fatty acids to the AREDS supplements on Age-Related macular degeneration progression: AREDS2 report 28. JAMA Ophthalmol. 2022;140(7):692\u20138.","journal-title":"JAMA Ophthalmol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00778-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00778-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:08:46Z","timestamp":1768342126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00778-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":244,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00778-7","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}